The California Prostate Cancer Coalition (CPCC) is a coalition of doctors, prostate cancer survivors (and families), nurses, support groups and others concerned about prostate cancer in California.
Recently diagnosed with prostate cancer or have questions?
Much has been written on the subject of prostate cancer including medical articles, research reports, and feature news articles. These have addressed prostate cancer occurrence among the male populations, research toward a cure, prostate cancer screening, prostate cancer treatment, and prostate cancer survival.
The CPCC site provides resources on all of these prostate cancer considerations. Our goal is help you get the answers to your questions so you can make informed decisions about prostate cancer.
FDA tags Bayer’s prostate cancer drug for priority review as drugmaker gears up against rivals
PROSPER: A Phase 3, Randomized, Double-blind, Placebo (PBO)-controlled Study of Enzalutamide (ENZA) in Men with Nonmetastatic Castration-Resistant Prostate Cancer (M0 CRPC)
Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.
Genetic Variants in HSD3B1 May Predict Outcomes of Prostate Cancer Treated With ADT or Abiraterone
Current Guidelines Unreliable for Detecting Germline Variants in Prostate Cancer
AR-V7 in CTCs Tied to Shorter Survival in Certain Patients with Metastatic CRPC
Chemo Plus Docetaxel Improves Survival, Reduces Metastasis in High-Risk Prostate Cancer
Genetics of Prostate Cancer (PDQ®)–Health Professional Version
EAU 2019: Pivotal Study of MRI-Guided Transurethral Ultrasound Ablation in Men with Localized Prostate Cancer: Preliminary Results
EAU 2019: Development of Novel Criteria for Active Surveillance Based on Multiparametric MRI Alone in Men with Gleason 3+4 Prostate Cancer
EAU 2019: Potentials of 68Ga-Prostate Specific Membrane Antigen PET/CT for Primary Diagnosis of Prostate Cancer
Testosterone Slows Prostate Cancer Recurrence in Low-Risk Patients
Hormonal Treatment May Trigger Depression in Men with Prostate Cancer
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.
EAU 2019: The Urologist’s Perspective on Active Surveillance
EAU 2019: The Medical Oncologist’s Perspective on the Treatment for Prostate Cancer
The California Prostate Cancer Coalition (CPCC) is proud to partner with UCSF’s Helen Diller Family Comprehensive Cancer Center to present The 2019 Patient Conference on Prostate Cancer, on June 8, 2019, from 8:00 am – 5:00 pm. This conference is a great educational opportunity for patients, families, caregivers, advocates, nurses, health care providers, and all others interested in prostate cancer and how to improve the quality of life for patients!
Registration is now open!
Prostate Cancer Risk After Single Negative Biopsy Quantified